60 mg vial tirzepatide Tirzepatide Munjaro 60mg x1 vial

Mild redness, stinging, and small bruising are common and typically resolve within 24-48 hours

Meto's resources on metabolic syndrome and fatty liver disease provide relevant context for why VAT reduction translates to systemic metabolic benefit

Both require lifestyle changes in the long term to sustain results

Purpose ELIXA was conducted to assess the cardiovascular safety of once-daily subcutaneously injected lixisenatide 20 mcg (Adlyxin) by documenting non-inferiority, as well as superiority, for the primary composite outcome of non-fatal myocardial infarction, non-fatal stroke, CV death, or hospitalization for unstable angina (4-point MACE) in an adult population with T2DM and extremely high CV risk

doi:10.1016/j.jacc.2015.10.017 Guglin M, Zucker MJ, Bazan VM, et al